Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Amado J Karduss"'
Autor:
José A. Fernández-Gutiérrez, Oscar A. Reyes-Cisneros, Mark R. Litzow, Lorena Bojalil-Álvarez, Elizabeth García-Villaseñor, Eliezer Tomas Gómez-Gomez, Iván Murrieta-Álvarez, David Gomez-Almaguer, Cesar H. Gutierrez-Aguirre, Amado J. Karduss-Urueta, Guillermo J. Ruiz-Delgado, Guillermo José Ruiz-Argüelles
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 449-455 (2022)
Introduction High-dose melphalan (HD-Mel) has been successfully employed in autografting patients with multiple myeloma. An advantage of this regimen is that the total dose of Mel can be delivered in a single day, being particularly useful when non-f
Externí odkaz:
https://doaj.org/article/fa4ee3b7bae5467c86d85eb20a31901d
Autor:
Marlon Castrillon, Nancy D. Marin, Amado J. Karduss-Urueta, Sonia Y. Velasquez, Cristiam M. Alvarez
Publikováno v:
Cells, Vol 11, Iss 18, p 2776 (2022)
Natural Killer (NK) cells are innate immune cells that mediate antiviral and antitumor responses. NK cell activation and induction of effector functions are tightly regulated by the integration of activating and inhibitory receptors such as killer im
Externí odkaz:
https://doaj.org/article/18d038569b8a4f0ea1ecdadd5e56d4dd
Autor:
Molly C. Tokaz, Helen Baldomero, Andrew J. Cowan, Wael Saber, Hildegard Greinix, Mickey B.C. Koh, Nicolaus Kröger, Mohamad Mohty, Sebastian Galeano, Shinichiro Okamoto, Naeem Chaudhri, Amado J. Karduss, Fabio Ciceri, Vergílio Antonio R. Colturato, Selim Corbacioglu, Alaa Elhaddad, Lisa M. Force, Cristóbal Frutos, Andrés Gómez-De León, Nada Hamad, Nelson Hamerschlak, Naya He, Aloysius Ho, Xiao-jun Huang, Ben Jacobs, Hee-Je Kim, Minako Iida, Leslie Lehmann, Regis Peffault de Latour, Mary-Elizabeth M. Percival, Martina Perdomo, Walid Rasheed, Kirk R. Schultz, Adriana Seber, Bor-Sheng Ko, Anderson João Simione, Alok Srivastava, Jeff Szer, William A. Wood, Yoshihisa Kodera, Arnon Nagler, John A. Snowden, Daniel Weisdorf, Jakob Passweg, Marcelo C. Pasquini, Anna Sureda, Yoshiko Atsuta, Mahmoud Aljurf, Dietger Niederwieser
Publikováno v:
Blood. 140:8146-8149
Acute myeloid leukemia (AML) has an aggressive course and a historically dismal prognosis. For many patients, hematopoietic stem cell transplantation (HSCT) represents the best option for cure, but access, utilization and health inequities on a globa
Autor:
Pamela Velásquez-Salazar, Amado J Karduss, Gilma N Hernandez, Angelica Cardona, Hector Ivan Garcia
Publikováno v:
Blood. 140:12824-12825
Autor:
Guillermo Herrera, Amado J Karduss-Urueta, Deisy Johana Herrera, Angelica Cardona, Sigifredo Ospina, Pamela Velazquez
Publikováno v:
Transplantation and Cellular Therapy. 29:S337
Publikováno v:
The New England journal of medicine. 384(18)
Autor:
Amado J Karduss-Urueta, Francesca Ferraro, Dongyun Yang, Stefan O. Ciurea, Mohamad Mohty, Ryotaro Nakamura, Gérard Socié, Armin Ghobadi, Yener Koc, Boris V. Afanasyev, Myriam Labopin, Martin Bornhäuser, Stephen J. Forman, Partow Kebriaei, Richard E. Champlin, Monzr M. Al Malki, Arnon Nagler, Grzegorz Helbig, Sally Mokhtari, Asad Bashey, Arne Brecht, Fabio Ciceri, Arnold Ganser, Emanuele Angelucci, Nelli Bejanyan, Riitta Niittyvuopio
Publikováno v:
Blood Adv
We compared outcomes of 1461 adult patients with acute lymphoblastic leukemia (ALL) receiving hematopoietic cell transplantation (HCT) from a haploidentical (n = 487) or matched unrelated donor (MUD; n = 974) between January 2005 and June 2018. Graft
Autor:
Rizwan Romee, Richard E. Champlin, Partow Kebriaei, Scott D. Solomon, Denái R. Milton, Stephan J. Forman, R. Pérez, Gabriela Rondon, Stefan O. Ciurea, Auayporn Nademanee, Stacey Brown, Monzr M. Al Malki, Michael Slade, Samer A. Srour, Amado J Karduss-Urueta, Asad Bashey
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:318-324
Haploidentical transplantation performed with post-transplantation cyclophosphamide (PTCy)–based graft-versus-host disease (GVHD) prophylaxis has been associated with favorable outcomes for patients with acute myeloid leukemia and lymphomas. Howeve
Autor:
Giovanni Ruiz, Jose Betancur, Gloria Suarez, Angela Maria Trujillo, Amado J Karduss-Urueta, R. Pérez, Luis Rodolfo Gomez, Monica Ramirez, Pedro Reyes, A. Jiménez, Angelica Cardona
Publikováno v:
Blood. 128:2192-2192
Introduction The use of Haploidentical Transplantation (haploSCT) with pos-transplantation cyclophosphamide (PTCy) has become in a very good alternative for patients with acute leukemia who need a transplant but without a well matched donor, however,
Autor:
Pedro Reyes, Miguel Gonzalez Velez, Liliana Hurtado, Amado J Karduss-Urueta, Clara Fernandez, Ana Cardona, R. Pérez, Luis Rodolfo Gomez, Hilda Deossa, Juan A. Jimenez
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 25:C82-C82
Introduction: Autologous stem cell transplantation (ASCT) is the standard of care for treating patients with advanced lymphomas. The most commonly employed preparative regimens are BCNU (Carmustine), etoposide, cytosine arabinoside, melphalan (BEAM),